Zumiez (ZUMZ) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
10 Sep, 2026Executive summary
Net sales for Q2 2026 decreased 2.5% year-over-year to $209 million, primarily due to U.S. market softness and a 2.1% decline in comparable sales, while international entities delivered positive sales growth.
U.S. sales deceleration was driven by declines in footwear and overall transactions, with footwear accounting for 70% of the U.S. sales decline.
International business saw low single-digit positive comparable sales, supported by refreshed product mix and private label growth.
Net loss for Q2 2026 was $2.7 million ($0.17 per share), compared to $1 million ($0.06 per share) in the prior year.
For the six months ended August 1, 2026, net sales increased 0.9% to $402.3 million, with a net loss of $16 million ($1.00 per share).
Financial highlights
Gross profit for Q2 2026 was $73.9 million, with gross margin at 35.3%, down 20 bps year-over-year.
Operating loss for Q2 2026 was $1.3 million (0.6% of net sales), compared to prior year operating income of $0.1 million.
SG&A expense was $75.2 million (35.9% of net sales), up 50 bps as a percentage of sales.
Cash and marketable securities at quarter-end were $97.3 million; total assets were $627.4 million.
Net cash used in operating activities for the six months was $27.3 million, up from $9.5 million in the prior year period.
Outlook and guidance
Q3 FY26 net sales expected between $222 million and $226 million, a 5.5%-7% decline year-over-year.
Comparable sales for Q3 projected between -5% and -6.5%; product margin expected down 20-40 bps.
Q3 operating income expected at 1%-1.7% of sales; EPS forecasted between $0.00 and $0.10.
Full-year sales expected to be down low single digits, including a $12 million negative impact from store closures.
Five new stores planned and 16 closures for FY26; capital expenditures projected at $13–$15 million.
Latest events from Zumiez
- Q1 FY2026 sales and margins improved, but Q2 outlook is cautious due to consumer headwinds.ZUMZ
Q1 2027 - Proxy covers director elections, executive pay, auditor ratification, and ESG priorities.ZUMZ
Proxy filing - Director elections, executive pay, and auditor ratification headline the June 2026 meeting.ZUMZ
Proxy filing - Strong Q4 and FY25 results with margin gains and a new $40M buyback authorized.ZUMZ
Q4 2026 - Q3 sales and EPS surged, with strong North America growth and positive Q4 outlook.ZUMZ
Q3 2026 - Q3 net sales up 2.9%, comp sales up 7.5%, and margins improved; Q4 outlook remains strong.ZUMZ
Q3 2025 - Q2 net sales rose 8.1%, gross margin expanded, and net loss narrowed on strong comps.ZUMZ
Q2 2025 - Gross margin rose to 29.3% as net loss narrowed and a $25M buyback was authorized.ZUMZ
Q1 2025 - Sales up 3.9%, gross margin at 30.0%, net loss narrowed, North America led growth.ZUMZ
Q1 2026